Analysis of whether pirfenidone has been included in medical insurance and reimbursement conditions

Pirfenidone (Pirfenidone) is an anti-fibrotic drug mainly used to treat idiopathic pulmonary fibrosis (IPF). At present, the original drug of this drug has been approved for marketing in China and has been included in the Category B scope of the National Medical Insurance List. This means that patients who meet the indications can reimburse part of the cost through medical insurance under a doctor's prescription, reducing the financial pressure of long-term medication. Since it is a Class B drug, the specific reimbursement ratio and amount will vary depending on regional medical insurance policies.

In the domestic market, the common specifications of pirfenidone are 100mg*54 capsules/ boxes, and the price is about RMB500 yuan. Considering that IPF patients usually require long-term or even lifelong medication, although medical insurance reimbursement can reduce part of the burden, there is still a certain amount of financial pressure on some patients. Therefore, how to take into account affordability while ensuring efficacy has become a common concern for patients and their families.

In addition to domestic original drugs, overseas markets also provide cheaper generic drugs. For example, the generic version of pirfenidone produced in India is relatively common. Its specification is 200mg*150 tablets/ box, and the price is only a few hundred yuan. Because their ingredients are highly consistent with the brand-name drugs, these generic drugs provide an alternative for some patients. However, it should be noted that when obtaining drugs through overseas channels, you need to be cautious and ensure that the sources are regular to avoid risks caused by counterfeit or inferior drugs.

In China, if patients want to be reimbursed through medical insurance, they must meet the indications for pirfenidone, that is, be diagnosed with idiopathic pulmonary fibrosis (IPF) and be prescribed it in a regular hospital. Patients should consult the local medical insurance department or designated hospital in advance for specific reimbursement ratios and procedures in order to reasonably plan treatment costs. At the same time, you should take medicines under the guidance of a doctor and do not stop or change medicines on your own due to price issues, so as not to affect disease control.

Reference materials:https://www.drugs.com/